Xin Fang Li

Director Ejecutivo en MabPlex International Co., Ltd. .

57 años

Health Technology

Consumer Services

Perfil

Xin Fang Li is currently the CEO, General Manager & Director at MabPlex International Co., Ltd.
Prior to this, they earned a doctorate degree from Peking University in 1997.

Cargos activos de Xin Fang Li

Empresas	Cargo	Inicio
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Director Ejecutivo	01/01/2022

Todos los cargos activos de Xin Fang Li

Formación de Xin Fang Li.

Peking University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Xin Fang Li.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
MabPlex International Co., Ltd. MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China.	Health Technology